161 related articles for article (PubMed ID: 21802442)
1. Physiological and subjective effects of acute intranasal methamphetamine during atomoxetine maintenance.
Rush CR; Stoops WW; Lile JA; Glaser PE; Hays LR
Pharmacol Biochem Behav; 2011 Nov; 100(1):40-7. PubMed ID: 21802442
[TBL] [Abstract][Full Text] [Related]
2. Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance.
Rush CR; Stoops WW; Lile JA; Glaser PE; Hays LR
Psychopharmacology (Berl); 2011 Apr; 214(3):665-74. PubMed ID: 21072503
[TBL] [Abstract][Full Text] [Related]
3. Physiological and subjective effects of acute intranasal methamphetamine during extended-release alprazolam maintenance.
Lile JA; Stoops WW; Glaser PE; Hays LR; Rush CR
Drug Alcohol Depend; 2011 Dec; 119(3):187-93. PubMed ID: 21737214
[TBL] [Abstract][Full Text] [Related]
4. Safety, tolerability and subject-rated effects of acute intranasal cocaine administration during atomoxetine maintenance.
Stoops WW; Blackburn JW; Hudson DA; Hays LR; Rush CR
Drug Alcohol Depend; 2008 Jan; 92(1-3):282-5. PubMed ID: 17719727
[TBL] [Abstract][Full Text] [Related]
5. Separate and Combined Effects of Naltrexone and Extended-Release Alprazolam on the Reinforcing, Subject-Rated, and Cardiovascular Effects of Methamphetamine.
Marks KR; Lile JA; Stoops WW; Glaser PE; Hays LR; Rush CR
J Clin Psychopharmacol; 2016 Jun; 36(3):213-21. PubMed ID: 27043121
[TBL] [Abstract][Full Text] [Related]
6. Acute physiological and behavioral effects of intranasal methamphetamine in humans.
Hart CL; Gunderson EW; Perez A; Kirkpatrick MG; Thurmond A; Comer SD; Foltin RW
Neuropsychopharmacology; 2008 Jul; 33(8):1847-55. PubMed ID: 17851535
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users.
Heil SH; Holmes HW; Bickel WK; Higgins ST; Badger GJ; Laws HF; Faries DE
Drug Alcohol Depend; 2002 Jul; 67(2):149-56. PubMed ID: 12095664
[TBL] [Abstract][Full Text] [Related]
8. Buspirone maintenance does not alter the reinforcing, subjective, and cardiovascular effects of intranasal methamphetamine.
Reynolds AR; Strickland JC; Stoops WW; Lile JA; Rush CR
Drug Alcohol Depend; 2017 Dec; 181():25-29. PubMed ID: 29028556
[TBL] [Abstract][Full Text] [Related]
9. Influence of phendimetrazine maintenance on the reinforcing, subjective, performance, and physiological effects of intranasal cocaine.
Stoops WW; Strickland JC; Alcorn JL; Hays LR; Rayapati AO; Lile JA; Rush CR
Psychopharmacology (Berl); 2019 Sep; 236(9):2569-2577. PubMed ID: 30900008
[TBL] [Abstract][Full Text] [Related]
10. Safety of atomoxetine in combination with intravenous cocaine in cocaine-experienced participants.
Cantilena L; Kahn R; Duncan CC; Li SH; Anderson A; Elkashef A
J Addict Med; 2012 Dec; 6(4):265-73. PubMed ID: 22987022
[TBL] [Abstract][Full Text] [Related]
11. Residual effects of intranasal methamphetamine on sleep, mood, and performance.
Perez AY; Kirkpatrick MG; Gunderson EW; Marrone G; Silver R; Foltin RW; Hart CL
Drug Alcohol Depend; 2008 Apr; 94(1-3):258-62. PubMed ID: 18078723
[TBL] [Abstract][Full Text] [Related]
12. Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study.
Verrico CD; Haile CN; De La Garza R; Grasing K; Kosten TR; Newton TF
Int J Neuropsychopharmacol; 2016 Jul; 19(7):. PubMed ID: 27207905
[TBL] [Abstract][Full Text] [Related]
13. Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy.
Rush CR; Stoops WW; Hays LR
Drug Alcohol Depend; 2009 Jan; 99(1-3):261-71. PubMed ID: 18926645
[TBL] [Abstract][Full Text] [Related]
14. Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans.
Lile JA; Stoops WW; Durell TM; Glaser PE; Rush CR
Exp Clin Psychopharmacol; 2006 May; 14(2):136-47. PubMed ID: 16756417
[TBL] [Abstract][Full Text] [Related]
15. Discriminative-stimulus, subject-rated, and physiological effects of methamphetamine in humans pretreated with aripiprazole.
Sevak RJ; Vansickel AR; Stoops WW; Glaser PE; Hays LR; Rush CR
J Clin Psychopharmacol; 2011 Aug; 31(4):470-80. PubMed ID: 21694622
[TBL] [Abstract][Full Text] [Related]
16. Influence of aripiprazole pretreatment on the reinforcing effects of methamphetamine in humans.
Stoops WW; Bennett JA; Lile JA; Sevak RJ; Rush CR
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():111-7. PubMed ID: 23994622
[TBL] [Abstract][Full Text] [Related]
17. Naltrexone and bupropion, alone or combined, do not alter the reinforcing effects of intranasal methamphetamine.
Stoops WW; Pike E; Hays LR; Glaser PE; Rush CR
Pharmacol Biochem Behav; 2015 Feb; 129():45-50. PubMed ID: 25459104
[TBL] [Abstract][Full Text] [Related]
18. Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.
Garnock-Jones KP; Keating GM
Paediatr Drugs; 2009; 11(3):203-26. PubMed ID: 19445548
[TBL] [Abstract][Full Text] [Related]
19. Acute and residual interactive effects of repeated administrations of oral methamphetamine and alcohol in humans.
Kirkpatrick MG; Gunderson EW; Levin FR; Foltin RW; Hart CL
Psychopharmacology (Berl); 2012 Jan; 219(1):191-204. PubMed ID: 21748253
[TBL] [Abstract][Full Text] [Related]
20. Reinforcing, subject-rated, and physiological effects of intranasal methylphenidate in humans: a dose-response analysis.
Stoops WW; Glaser PE; Rush CR
Drug Alcohol Depend; 2003 Aug; 71(2):179-86. PubMed ID: 12927656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]